MedWatch

MSD sets carbon neutrality goal

On Monday, pharmaceutical company MSD lifts the veil for a list of new climate goals which will reduce the company's carbon footprint.

Photo: MSD / PR

Pharmaceutical company MSD, also known as Merck in the US and Canada, will reduce its impact on the climate in the coming years.

On Monday, the firm announced its goals to achieve carbon neutrality for so-called scope 1 and 2 emissions across its operations by 2025.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs